Cordyceps

• Aerobic capacity and endurance in older or unfit adults (modest, CS-4 strain)
• Perceived energy and fatigue resistance (traditional, weakly evidenced)
• Exercise tolerance and recovery (small trials, mixed)
• Lung and respiratory support (traditional tonic use)
• Libido and vitality (traditional; not clinically established)

Cordyceps contains cordycepin (3'-deoxyadenosine, the principal pharmacologically active nucleoside) and adenosine, along with beta-glucan polysaccharides. The proposed performance and energy mechanism involves enhanced ATP production and oxygen utilization at the mitochondrial level, plus modulation of erythropoietin signaling. Two species share the market: Cordyceps sinensis (wild-harvested Tibetan caterpillar fungus, severely depleted) and Cordyceps militaris (cultivated, comparable cordycepin content, dominant supplement form).

Cordyceps is typically dosed at 1-3g daily of cultivated C. militaris fruit body powder, or 500-1000mg 1-2 times daily of dual-extract concentrate (standardized to cordycepin and beta-glucan content). Take consistently, adaptogenic and immune modulation effects develop over 4-12 weeks of consistent supplementation rather than acute pharmacological effect. Some practitioners recommend cycling (8-12 weeks on, 2-4 weeks off) though substantial mechanistic rationale for cycling is limited; chronic supplementation appears reasonable for adaptogenic applications. Take with or without food, absorption is reasonable either way. For endurance performance applications, some practitioners recommend 1-3g supplementation for 4-12 weeks before event with optional pre-event dosing (1g 60-90 minutes before event); substantial evidence for acute pre-event ergogenic effect is limited. The substantial form-factor preference is cultivated C. militaris fruit body over wild C. sinensis (sustainability and verification advantages) and over mycelium-on-grain alternatives (substantially better active compound content). The substantial dual-extraction framework (hot water + ethanol) provides broadest pharmacological coverage. The drug interaction profile is modest at standard supplementation doses; anticoagulant users warrant coordination given mild antiplatelet effects, and immunosuppressant users warrant specialist coordination given beta-glucan immune modulation. Pregnancy and lactation: generally avoid given limited safety data; OB-GYN coordination if used. Pediatric use: specialist coordination given limited pediatric safety data.

Standard daily dose

1-3g cultivated C. militaris fruit body powder daily

Dual-extract dose

500-1000mg 1-2x daily

Cordycepin content

0.2-2% standardized (verify product specification)

Beta-glucan content

8-30% standardized

Treatment duration for chronic effects

4-12+ weeks

Form preference

Cultivated C. militaris fruit body > wild C. sinensis > mycelium-on-grain

Extraction preference

Dual extract (hot water + ethanol) > single extract > whole powder

Take with

With or without food

• Cordyceps militaris Cultivated Fruit Body Powder

  Rating: gold

  Substantially preferred form, cultivated C. militaris fruit body provides reliable cordycepin content (commonly 0.2-2% standardized) without the substantial ecological harm of wild C. sinensis collection. Most reputable supplement brands (Real Mushrooms, Host Defense, Nammex, Oriveda, Aloha Medicinals) now source from cultivated C. militaris. Sustainable framework; reliable pharmacology. Verify fruit body content (not mycelium-on-grain).

• Cordyceps militaris Hot Water + Ethanol Dual Extract

  Rating: gold

  Dual extraction (hot water for polysaccharides + ethanol for triterpenoids and nucleosides) yields the broadest pharmacological coverage. Standardized to 0.2-2% cordycepin and 8-30% beta-glucans. Premium positioning relative to single-extract or whole-powder alternatives. Substantially preferred for therapeutic applications.

• Cordyceps sinensis Wild-Harvested

  Rating: caution

  Historically the foundational form (yarsa gumba, Tibetan/Himalayan caterpillar fungus) but substantially overharvested through 2000s-2020s with substantial ecological damage to Himalayan ecosystems and substantial commercial fraud (adulteration with substandard species or synthetic cordycepin). Substantial price premium ($20,000-100,000/kg historically). Ethical and sustainability concerns substantial; verification challenges substantial. Generally avoid in favor of cultivated C. militaris.

• Cordyceps Mycelium-on-Grain (CS-4)

  Rating: caution

  Mycelium grown on rice or oats, substantially less expensive than fruit body but contains substantial grain starch (verify by iodine starch test) and substantially diluted active compound content versus fruit body. CS-4 strain (Paecilomyces hepiali, sometimes mislabeled as "Cordyceps") was developed in China as substantial commercial alternative. Reasonable budget option; substantially inferior to cultivated fruit body.

• Generic "Cordyceps" Without Species Specification

  Rating: caution

  Many products labeled "cordyceps" without specifying C. sinensis vs C. militaris, fruit body vs mycelium, or cordycepin content. Substantial commercial opacity; verify species and form specification before purchase.

• AG1 / Bloom / Huel Multi-Ingredient Cordyceps Content

  Rating: caution

  Multi-ingredient greens powders and adaptogen blends typically include modest cordyceps content (often <100mg per serving), substantially below therapeutic single-supplement dose ranges (1-3g daily). Users seeking therapeutic cordyceps effects should use dedicated standalone cordyceps supplementation.

• Functional Mushroom Coffee Blends (Four Sigmatic, Mushroom Coffee)

  Rating: good

  Mushroom-infused coffee products (Four Sigmatic and similar brands) include modest cordyceps content alongside other functional mushrooms. Reasonable consumer entry point; modest dosing relative to dedicated standalone supplementation.

• Performance Pre-Workout Cordyceps Inclusions

  Rating: good

  Various pre-workout and endurance performance products include cordyceps content for proposed oxygen utilization and ATP production enhancement. Modest dosing typical; substantial marketing claims often exceed evidence base.

• Endurance athletes and aerobic performance contexts

  Strength of evidence for this group: modest

  Substantial historical popularity following 1993 Chinese national women's track team performance attribution (substantially overinterpreted). Modest objective evidence for VO2 max, time-to-exhaustion, or substantial endurance performance markers in well-designed RCTs, Chen 2010 (Stanford) showed modest TTE improvement; broader replication inconsistent. Reasonable adjunctive supplementation; not substantial ergogenic intervention.

• Adults seeking modest energy and vitality support

  Strength of evidence for this group: modest

  Traditional Tibetan/Chinese use framework emphasizes "vitality" applications; modern evidence supports modest subjective energy improvements through proposed mitochondrial mechanisms. Reasonable adaptogenic supplementation; effect sizes modest.

• Older adults seeking adaptogenic and immune support

  Strength of evidence for this group: modest

  Traditional applications include older adult vitality and immune support. Modest evidence for immune modulation through beta-glucan polysaccharide mechanisms; reasonable adjunctive supplementation framework.

• Adults seeking libido and sexual function support

  Strength of evidence for this group: cautious

  Traditional applications include sexual function support; modest preclinical evidence with limited human RCT translation. Reasonable adjunctive supplementation; consider standalone alternatives (maca, fadogia agrestis, tongkat ali) for users prioritizing dedicated intervention.

• Pregnancy and lactation

  Strength of evidence for this group: cautious

  Limited pregnancy and lactation safety data. Traditional use frameworks did not exclude pregnancy but modern conservative supplementation guidance generally recommends avoidance during pregnancy. OB-GYN coordination essential.

• Anticoagulant users

  Strength of evidence for this group: cautious

  Cordyceps has modest antiplatelet effects through cordycepin and adenosine content; theoretical warfarin and DOAC interaction. Generally well-tolerated at standard dosing; coordinate with anticoagulation management for substantial use.

• Immunosuppressant users

  Strength of evidence for this group: cautious

  Beta-glucan immune modulation may theoretically interact with immunosuppressant therapy. Coordinate with transplant medicine or autoimmune disease specialists.

• Diabetes and glycemic management contexts

  Strength of evidence for this group: cautious

  Modest preclinical hypoglycemic activity; theoretical hypoglycemic medication interaction. Generally well-tolerated; monitor glycemic markers during initial supplementation.

• Pediatric use

  Strength of evidence for this group: cautious

  Limited pediatric safety data; specialist coordination if pediatric supplementation considered. Adult formulations not designed for pediatric supplementation.

• WADA-tested athletes

  Strength of evidence for this group: cautious

  Cordyceps not on WADA prohibited list; contamination concerns affect supplement category broadly. Verify third-party testing (NSF Certified for Sport, Informed Sport) for WADA-tested athletes.

• Multi-Adaptogen Stacks (Rhodiola, Ashwagandha, Schisandra)

  Interaction: synergy

  Reasonable combination with other adaptogens for comprehensive vitality framework. Each adaptogen provides distinct mechanism profile; combination provides broader pharmacological coverage. Traditional Chinese medicine frameworks integrate cordyceps with multiple adaptogenic herbs.

• Endurance Performance Supplementation (Beta-Alanine, Beetroot/Nitrate, Creatine)

  Interaction: synergy

  Reasonable combination with established ergogenic supplements for endurance contexts. Different mechanism profiles; modest cordyceps contribution alongside more established ergogenic frameworks.

• Other Functional Mushrooms (Reishi, Lion's Mane, Turkey Tail, Chaga)

  Interaction: synergy

  Reasonable combination for comprehensive functional mushroom supplementation; each mushroom provides distinct pharmacological profile. Multi-mushroom blends provide broader coverage at modest individual mushroom doses.

• Coffee and Caffeine

  Interaction: synergy

  Modest cordyceps integration in mushroom coffee products (Four Sigmatic and others). No substantial direct interaction; reasonable consumer convenience framework.

• Anticoagulants (Warfarin, DOACs)

  Interaction: caution

  Modest antiplatelet effects through cordycepin and adenosine content; theoretical warfarin INR and DOAC interaction. Coordinate with anticoagulation management for substantial use.

• Immunosuppressants (Cyclosporine, Tacrolimus, Methotrexate)

  Interaction: caution

  Beta-glucan immune modulation may theoretically interact with immunosuppressant therapy. Coordinate with transplant medicine or autoimmune disease specialists.

• Hypoglycemic Medications

  Interaction: caution

  Modest preclinical hypoglycemic activity; theoretical interaction with diabetes medications. Monitor glycemic markers during initial supplementation; coordinate with diabetes management.

• Pregnancy

  Interaction: caution

  Limited safety data; generally avoid during pregnancy. OB-GYN coordination if used.

• Multi-Ingredient Greens Powders (AG1, Bloom, Huel)

  Interaction: caution

  Greens powders include modest cordyceps content insufficient for therapeutic intervention; users seeking therapeutic effects should use dedicated standalone supplementation rather than relying on greens powder modest doses.

• WADA-Tested Athletes

  Interaction: caution

  Cordyceps not on WADA prohibited list; verify NSF Certified for Sport or Informed Sport third-party testing for WADA-tested athletes.

Look for: specified species (cultivated C. militaris substantially preferred over wild C. sinensis or mycelium-on-grain alternatives); explicit cordycepin content (0.2-2% standardized); explicit beta-glucan content (8-30% standardized); fruit body (not mycelium-on-grain) verification; dual extraction framework (hot water + ethanol) for therapeutic positioning; reputable manufacturer with third-party testing disclosure (heavy metals, contamination); appropriate dose for intended application (1-3g daily). Avoid: products labeled "cordyceps" without species specification; mycelium-on-grain products with substantial starch content; wild C. sinensis given substantial sustainability concerns and adulteration risk; products without standardized active compound content disclosure; substantial price premium products without corresponding quality verification.

Cordyceps sinensis was first documented in Tibetan medicine in roughly 1500 CE, the famous Yartsa Gunbu ("winter worm, summer grass") that grows from the bodies of caterpillar larvae on the Tibetan Plateau. Traditional Chinese medicine incorporated it during the Qing dynasty (17th-19th centuries) as a tonic for lung and kidney function, libido, and post-illness recovery. Modern Western interest accelerated after the 1993 Chinese national track championships, where multiple Cordyceps-using athletes broke world records.

1. ~1500 CEFirst Tibetan medical documentation
2. 1600sQing dynasty incorporation into TCM
3. 1993Chinese track championships world records
4. 2000sWild sinensis depletion crisis emerges
5. 2010Chen athletic performance trial
6. 2017Hirsch Cs-4 endurance trial
7. 2020sSustainability and counterfeiting concerns mainstreamed

• Whether cultivated militaris and wild sinensis produce clinically distinguishable effects given comparable cordycepin content.
• Whether the athletic performance evidence translates to elite-athlete populations or is confined to deconditioned baseline.
• Optimal extraction method for cordycepin retention, hot water vs alcohol vs dual extraction.
• Whether the lung-function traditional indication has modern evidence (some preliminary signals in COPD and asthma trials).

Cultivated Cordyceps militaris is universally available as a dietary supplement. Wild Cordyceps sinensis is restricted by CITES-adjacent international wildlife trade conventions and is increasingly difficult to source legitimately. Cs-4 (the cultivated mycelial fermentation product) is the most-studied supplement form.

Status current as of July 2026. Regulatory positions change, sometimes quickly.

Active compound

Cordycepin (3'-deoxyadenosine)

Typical dose

1-3g/day extract

Practical species

Cordyceps militaris (cultivated)

Most-studied form

Cs-4 mycelial fermentation

Traditional source

Tibetan plateau wild sinensis

Sustainability

Cultivated militaris strongly preferred

What follows is unfinished work on our side, not a finding about Cordyceps. A short entry is not a safe entry.

• Cost and market. We have not documented what it sells for or who sells it.
• Supply chain. We have not mapped where it is made.
• Who uses it. We have not documented the user groups.
• What could change. No forward-looking summary yet.
• How it compares. We have not set it against the alternatives.
• Children and teenagers. We have not checked what is known about younger people.